Results 31 to 40 of about 102 (83)
Рациональная фармакотерапия в кардиологии, 2015 Data on the problem of thromboembolic complications in non-valvular atrial fibrillation are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties in drug choice and dosage adjustment are also ...
E. L. Dolgova +2 more
doaj +1 more source
Ривароксабан в лечении острого тромбоза вен нижних конечностей [PDF]
, 2015 ТРОМБОЗ ВЕНОЗНЫЙ /ЛЕК ТЕРКОНЕЧНОСТЬ ...
Кривощеков, Е. П. +1 more
core
Acta Biomedica ScientificaBackground. The use of P-glycoprotein (P-gp) inhibitors and carriage of certain ABCB1 polymorphisms can lead to increased concentrations of rivaroxaban and the development of bleeding.The aim of the study. To study the features of drug-drug interactions (
D. A. Sychev +9 more
doaj +1 more source
RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
Рациональная фармакотерапия в кардиологии, 2015 The possibilities of antithrombotic therapy in atrial fibrillation are highlighted. The alternative antithrombotic agents, including rivaroxaban presented along with the traditional drugs (acetyl-salicylic acid, warfarin).
M. Yu. Gilyarov
doaj +1 more source
COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
Рациональная фармакотерапия в кардиологии, 2015 Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed ...
V. A. Sulimov +2 more
doaj +1 more source
ПРИМЕНЕНИЕ ПЕРОРАЛЬНЫХ АНТИКОАГУЛЯНТОВ В ЛЕЧЕНИИ БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ
, 2017 The review discusses the results of using oral anticoagulants to improve the prognosis of patients after exacerbation of coronary artery disease. Based on a review of the available randomized clinical trials, the authors conclude that rivaroxaban at a ...
Н. Б. Перепеч, N. B. Perepech
core +1 more source
The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation
Медицинский совет, 2014 The article is a literature review on the problem of thromboembolic complications in non-valvular atrial fibrillation, the peculiarities of anticoagulant therapy and challenges associated with the selection of drugs for stroke prevention.
EL Dolgova, IM Sokolov, YG Schwarz
doaj +1 more source
, 2018 В обзоре обсуждается необходимость подкрепления данных, полученных в рандомизированных клинических исследованиях (РКИ), результатами реальной клинической практики (РКП). Оба метода получения информация обладают недостатками.
Anna Ivanova (6059813)
core +1 more source
Pulmonary embolism: inpatient and outpatient treatment
Медицинский совет, 2014 Pulmonary embolism (PE) is a rather common emergency situation. Occlusion of pulmonary arteries of different calibre may result in critical condition, shock, sudden death, while in a number of patients who survived thromboembolism it may lead to long ...
GE Gendlin +3 more
doaj +1 more source
Venous thromboembolism - Expanding therapeutic options
Медицинский совет, 2013 Venous thromboembolism (VTE) is caused by the formation of blood clots within a vein resulting in vein occlusion and risk of blood clots travelling to the pulmonary arteries.
I. A. Filippova
doaj +1 more source